PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 433615-0 1979 The effect of metformin on the arginine induced insulin- and glucagon release in pigs. Metformin 14-23 insulin Sus scrofa 48-55 16784971-8 2006 Metformin vs placebo treatment of diabetic pigs (twice 1.5 g/d) for 2 weeks during isoenergetic feeding (1045 kJ/kg body weight(0.75)) resulted in a reduction in both fasting and postprandial hyperglycemia (14.7 +/- 1.5 vs 19.4 +/- 0.6 and 24.9 +/- 2.2 vs 35.5 +/- 4.9 mmol/L), a reduction in daily urinary glucose excretion (approximately 250 vs approximately 350 g/kg food), and an increase in insulin-stimulated glucose disposal (9.4 +/- 2.2 vs 5.8 +/- 1.7 mg kg(-1) min(-1); P < .05), respectively. Metformin 0-9 insulin Sus scrofa 396-403 23083540-0 2013 Metformin alters the insulin signaling pathway in ischemic cardiac tissue in a swine model of metabolic syndrome. Metformin 0-9 insulin Sus scrofa 21-28 23083540-1 2013 OBJECTIVE: The purpose of this study is to evaluate the effect of metformin on insulin signaling in ischemic cardiac tissue in a swine model of metabolic syndrome. Metformin 66-75 insulin Sus scrofa 79-86 23083540-11 2013 CONCLUSIONS: Metformin treatment in the context of metabolic syndrome and myocardial ischemia dramatically upregulates the insulin signaling pathway in chronically ischemic myocardium, which is at the crossroads of known metabolic and survival benefits of metformin. Metformin 13-22 insulin Sus scrofa 123-130 23083540-11 2013 CONCLUSIONS: Metformin treatment in the context of metabolic syndrome and myocardial ischemia dramatically upregulates the insulin signaling pathway in chronically ischemic myocardium, which is at the crossroads of known metabolic and survival benefits of metformin. Metformin 256-265 insulin Sus scrofa 123-130 22048751-5 2012 The hypothesis was disproved, as we have shown that insulin and metformin, like insulin, directly stimulate NO production by endothelium of a conduit artery; this function may be of value in delaying the atherothrombotic process. Metformin 64-73 insulin Sus scrofa 80-87